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We studied changes in apathy among 77 community-dwelling older persons with mild memory loss in a randomized clinical trial
comparing two nonpharmacologicalinterventions over four weeks. The study used a pre-post design with randomization by site
to avoid contaminationand diﬀusion of eﬀect. Interventions were oﬀered twice weekly after baseline evaluations were completed.
The treatment group received classroomstyle mentallystimulatingactivities (MSAs)while the control group received a structured
early-stage social support (SS) group. The results showed that the MSA group had signiﬁcantly lower levels of apathy (P<. 001)
and signiﬁcantly lower symptoms of depression (P<. 001). While both groups improved on quality of life, the MSA group was
signiﬁcantly better (P = .02) than the SS group. Executive function was not signiﬁcantly diﬀerent for the two groups at four
weeks, but general cognition improved for the MSA group and declined slightly for the SS group which produced a signiﬁcant
posttest diﬀerence (P<. 001). Recruitment and retention of SS group members was diﬃcult in this project, especially in senior
center locations, while this was not the case for the MSA group. The examination of the data at this four-week time point shows
promising results that the MSA intervention may provide a much needed method of reducing apathy and depressive symptoms,
while motivating participation and increasing quality of life.
1.Introduction
Neuropsychiatric symptoms of dementia are common and
associated with poor outcomes for patients and caregivers
[1]. Apathy is the most common neuropsychiatric symptom
in mild to moderate stages of Alzheimer’s disease (AD) and
increases in severity as the dementia progresses. Apathy is
complex to treat in AD since it is often mixed with other
challenging behaviors and confused with depression [2]. A
review of scientiﬁc evidence shows that pharmacological
therapies are not particularly eﬀective for management of
these mixed symptoms and further complicated by danger-
ous side eﬀects[3]. With an estimated 5.5 million Americans
with dementia, safe, eﬀective, and easy to deliver therapies
are desperately needed for this problem [1, 3–5].
Apathy is deﬁned as the loss of motivation not attributa-
ble to cognitive impairment, emotional distress, or reduced
level of consciousness [5]. Apathy occurs in approximately
70% of Alzheimer’s disease (AD) patients within ﬁve years
of diagnosis [6]. AD patients with apathy require more
management and support, given their reliance on others
to schedule their activities and initiate tasks even when
they are still physically capable of performing them. Studies
examining the relationship of apathy to neuropsychological
measures showed that apathy was consistently associated
with more severe functional impairments, more severe
cognitive deﬁcits, higher levels of burden and distress in
caregivers, along with increased resource utilization [7, 8].
Apathy in early-stage AD is often overlooked by health-
care providers, yet if left untreated, leads to more rapid than
expected functional decline [9]. The etiology of apathy is
complex and thought to be related to underlying pathology,
atrophy of the frontal lobes, and their connections to the
temporal lobes [10]. Damage to these areas of the brain2 Journal of Aging Research
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Figure 1: Theoretical model for apathy and the MSA intervention.
reduces the ability to initiate, sequence, and complete tasks.
Such losses can lead to unmet needs for cognitive, social,
emotional, and physical stimulation.
Older individuals with early-stage memory problems
have unmet needs with respect to stimulation, socialization,
needsforadaptation oftasks forsuccessful performance, and
yet have a desire for novel mentally stimulating experiences
to maintain abilities [2, 11–16]. Research shows that patients
with Mild Cognitive Impairment (MCI) and early-stage AD
continue to respond well to stimulation, often performing
at the same levels of brain activity as age-matched controls
[17,18].Whilethecurrent“state-of-the-art”interventionfor
early-stage dementia is an early stage support group, those
with apathy may not attend or may not beneﬁt in the same
way as more motivated participants.
Expanding on Marin’s Model of Apathy [19]( F i g u r e1),
we hypothesize that Mentally Stimulating Activities (MSAs)
that match current skill levels should be more eﬀective in
engaging participants with apathy and early-stage memory
loss because they meet individual needs for stimulation
while leading to more focused and successful therapeutic
experiences. Further, when engaged in MSAs with others,
in classroom-style groups, positive emotions should increase
and pleasant experiences with others occur. Finally, the
physical performance that takes place in each MSA session
reduces motor apathy and provides game-like opportunities
for active engagement again. These three subcomponents
work together to reduce motor, cognitive, and emotional
apathy, allow for failure-free enhanced engagement with
others, and theoretically could help participants maintain
function and improve QOL. This randomized controlled
trial (RCT) oﬀered participants either a course in classroom
style MSAs or a structured early-stage social support (SS)
group for symptoms of early-stage memory loss. This paper
will presentthe impact ofa 2-armRCT cognitivestimulation
intervention on apathy, depression, executive function, and
cognition in a subset of participants after 4 weeks of
intervention.The fully poweredcompletestudy will have120
participants with repeated measures at baseline, four weeks,
eight weeks, and 12 weeks.
2.Methods
2.1. Study Design and Participants. The ﬁrst 77 participants
randomized in the trial with pretest and 4-week posttest
scores are included in this paper. Randomization by site
(n = 8 sites) rather than by participant was used to control
for possible cross-contamination of treatment or diﬀusion
of eﬀect. The participants to date were recruited from
Continuing Care Retirement Communities and local senior
centers in central North Carolina and met the following
inclusion criteria: English speaking; 60 years of age or older;
diagnosis of dementia or symptoms that meet DSM-IV [20]
criteria for probable early-stage AD or Peterson criteria for
MCI [21]; a Mini-Mental State Exam (MMSE) [22]s c o r eo f
18orgreaterbutlessthan28;stableonanypsychoactivedrug
from prebaseline through ﬁnal observation to control for the
eﬀect these drugs have on neuropsychiatric behavior; and
presence of apathy as reported by family, signiﬁcant other,
or medical provider. Exclusion criteria included delirium or
a progressive, unstable medical, metabolic, or neurological
illness that might interfere with behavior; recent fracture
(within 4 months); history of Parkinson’s disease, Hunt-
ington’s disease, seizure disorder, major stroke, alcoholism,
drug abuse, recent head trauma with loss of consciousness,
or psychiatric illness preceding the onset of memory loss;
severe vision or hearing impairment; and receiving a new
psychoactivemedicationwithinthepast30days.Participants
were screened for inclusionby aGeriatric Nurse Practitioner,
and for cases without cognitive diagnoses the study PI or
medical director was consulted before the participant was
included. The IRB of the University of North Carolina at
Greensboro provided human subjects approval and data
safety and monitoring for this study.
2.2. Mentally Stimulating Activity Program. The MSA pro-
gram was developed by Fitzsimmons [23, 24] and has been
used in community-based, hospital, and long-term care
settings by the ﬁrst and second authors in clinical practice.
Speciﬁc cognitive tasks target attention, orientation, concen-
tration, short-term memory, and organized thinking in a
classroom style setting. Ingeneral,activities were designed to
be stimulating, challenging, novel, and fun but not frustrat-
ing. Eachtask takesfrom 2–10 minutes and is interactive and
goal driven. The one hour, twice weekly sessions included a
varietyofphysicalandcognitiveactivities thatrelyonvarious
functions ofthebrain:visualspatial abilities,verbalandnon-
verbal communication skills, abstract concepts, eye-hand
coordination, ﬁne motor control, body orientation, crossing
the midline, recognition memory, short-and long-termJournal of Aging Research 3
Table 1: Participant demographics (values are presented as n (%) or mean (standard deviation)).
Total Control (socialsupport) Treatment (mentally stimulating activities) P value
Participants (n) 77 29∗ 48
Gender .243
Male 15 (19.5%) 4 (13.8%) 11 (22.9%)
Female 62 (80.5%) 25 (86.2%) 36 (77.1%)
Race .071
Caucasian 56 (72.7%) 17 (58.6%) 39 (81.3%)
African-American 20 (25.9%) 11 (37.9%) 9 (18.7%)
Hispanic 1 (1.3%) 1 (.03%) 0 (0%)
Depression DX .594
Yes 20 7 (24.1%) 13 (27.1%)
No 57 22 (75.9%) 35 (72.9%)
Mean Age 82.2 (6.5) 81.0 (8.7) .07
Years of Education 13.6 (3.8) 14.6 (3.6) .499
Baselines
MMSE 25.4 (2.8) 25.2 (3.3) .269
AES (Apathy) 30.4 (7.9) 32.8 (8.7) .331
Cornell-Brown 18.6 (11.3) 14.3 (10.8) .758
PHQ-9 4.7 (4.8) 5.9 (5.7) .188
Trail MakingTime 192.80 (89.7) 178.45 (90.0) .635
∗48participantswereenrolled but 19dropped afterbaselinerecruitment and evaluationdueto healthproblemsandlackofinterestintheintervention (39%).
These participants were not includedin the pre-post analysis.
memory, executive functioning, and sensory identiﬁcation.
The facilitated tasks were performed by participants alone,
in pairs, or as a group. Participants were encouraged to ﬁnd
alternatemethodstocompletethetasksandwereencouraged
to help each other.
2.3. Structured Early-Stage Social Support Program. The SS
program was developed as a structured psychoeducational
group with information about brain health, group discus-
sion, and emotional support provided during each session.
The trained facilitator provided the structure and led
the discussion. Group members were encouraged to share
frustrations, concerns, and thoughts on dealing with the
emotional, social, and everyday problems that accompany
memory loss. Sessions were provided twice weekly for one
hour to provide an equivalent amount of social contact.
3.Data Collection
The following measures of psychological and cognitive
functioning were obtained at baseline and after four weeks
of the intervention by trained research assistants who were
blinded to the participant’s group assignment: apathy was
measured using the Apathy Evaluation Scale (AES) [19]. The
AES is an 18-item scale measuring things such as interests,
starting and completing things, and initiating activities.
Internal consistency is good, with an alpha ranging of
0.86–0.94. Depressive symptoms were measured with the
Patient Health Questionnaire (PHQ-9) [25]. The PHQ-9 is
a 9-item scale with scores ≥10 having a sensitivity of 88%
and a speciﬁcity of 88% for major depression. The Cornell-
Brown QOL [26] was used to measure quality of life.
Interrater reliability (intraclass r = 0.90) and internal
consistency reliability (Cronbach alpha = 0.81) are very
good. Global cognition was measured with the Mini-Mental
State Examination (MMSE) which consists of 11 simple
questions or tasks. Test-retest reliability is excellent (r>
0.89). Attentionand executive functions were measured with
the Trail Making test part B [27]( T a b l e3). Table 2 displays
evaluation tools used in the study.
3.1. Statistical Methods. Chi-Square tests and t-tests were
used to describe the participants by treatment assignment at
baseline.Todeterminetheimpactoftheinterventiononout-
c o m e sa tf o u rw e e k s ,A n a l y s i so fC o v a r i a n c e( A N C O V A )w a s
used. Between group diﬀerences are presented and adjusted
for baseline scores. Statistical analyses were performed with
PASW Statistics 18 software. Statistical signiﬁcance for the
study was established at P<. 05.
4.Results
Demographicsoftheﬁrst 77participants arelistedinTable1.
The control group (structured social support) had an attri-
tion of eighteen participants (37%) after baseline screening
and beforetheposttest evaluationstookplace.The treatment
group (mentally stimulating activities) had only one drop-
outthusthegroupsreported inthispaperare unevenwith29
in control and 48 in treatment due to high SS attrition after
intervention assignment. Examining the participants that
remained inthestudyforfourweeks,wefoundnosigniﬁcant
diﬀerence between groups inbaseline age, education, apathy,
depression, or MMSE scores. The treatment group had
slightly more depressive symptoms on the PHQ-9, slightly4 Journal of Aging Research
Table 2: Variables and measurement.
Cognition and Eligibility
for study
Mini-Mental State examination
(MMSE) [22]
The MMSE consists of 11 simple questions or tasks.
Test-retest reliability (r>0.89).
Neuropsychiatric behaviors Clinician administered Apathy
Evaluation Scale (AES) [19]
The AES is an 18-item scale. Internal consistency has an
alpha range of 0.86–0.94.Validity:diﬀerences found
P<. 05
Quality of life Cornell-Brown QOL [24] Interrater reliability (intraclass r = 0.90) and internal
consistency reliability (Cronbach alpha = 0.81).
Depression The Patient Health Questionnaire [25]
(PHQ-9)
Nine-item scale with PHQ-9 score ≥10 had a sensitivity of
88% and a speciﬁcity of 88% for major depression.
Executive function Trail Making B [26] Validity is high, especially when measuring attention and
executive function
Table 3: Analyses of covariance summary table for the eﬀect of treatment.
Adjusted means at baseline Adjusted means at 4 weeks nFSigniﬁcance (P value)
Apathy SS 30.38 35.52 29 31.496 <.001
MSA 32.08 28.19 48
Cornell Brown QOL SS 18.62 20.52 29 4.978 .029
MSA 14.31 22.92 48
MMSE SS 25.41 24.79 29 22.429 <.001
MSA 25.17 26.10 48
PHQ-9 SS 4.66 6.48 29 13.319 <.001
MSA 5.94 4.55 48
Trail making SS 192.20 178.89 29 .022 .258 (n.s)
MSA 184.73 161.42 48
more apathy, and slightly poorer quality of life reported on
the Cornell-Brown Scale prior to intervention.
After four weeks of intervention, the participants in the
MSA group had signiﬁcantly lower apathy scores than those
in the SS group. Speciﬁcally, the MSA group dropped 3.9
points on the Apathy Evaluation Scale-Clinical Version and
the SS group increased 5.1 points (P = .001). Quality of
life as measured by the Cornell Brown Scale improved for
both groups but the MSA group was signiﬁcantly better
(P<. 02). The MSA group improved 8.62 points, and the SS
group improved 1.9 points. Participants in the MSA group
improved by .93 on the MMSE (P = .001) and the SS group
declined by .62 indicating a signiﬁcant improvement in
cognition occurred for the MSA group after removing the
inﬂuence of pretest scores. While 57 participants did not
indicatedepression diagnosisatbaseline,asigniﬁcant change
occurred in both groups on the PHQ-9 after four weeks.
Participants in the MSA group had a 1.39 point drop, and
the SS group had a 1.82 point increase in depression scores
(P<. 001) after removing the inﬂuence of pretest scores.
Neither group was signiﬁcantly diﬀerent on the Trail Making
test.
5.Discussion
In this four-week study of 77 participants with early-
stage memory loss and apathy, those taking part in the
MSA sessions improved signiﬁcantly in the areas of apathy,
depressive symptoms, and quality of life in comparison to
those in the structured social support sessions. A small
improvement in mean MMSE score also occurred for the
MSA group but the primary target for this study was apathy.
We did not ﬁnd any diﬀerence in executive function at week
four, but perhaps the intervention will take longer to aﬀect
a change in executive function. These improvements are
consistent with the ﬁndings of earlier studies [28, 29]. Our
focus on reducing apathy may provide a novel therapeutic
routetoimprovingmoodandqualityoflife,andmaintaining
cognitive function over time. The early-stage support group
experienced a37%attrition rate,and forthose thatremained
at the four week posttest, there was a signiﬁcant increase
in apathy symptoms. These apathy symptoms could explain
poorer performance on the evaluation scales.
Most cognitive stimulation or cognitive training trials
have targeted healthy older adults and have found improve-
ments on speciﬁc tasks [30]. This trial took a diﬀerent
approach with the focus on breaking the pattern of apathy
during early stages of memory loss, which other studies have
shown to lead to premature functional decline. For people
with Alzheimer’s disease, cognitive stimulation therapy that
provides activities involving cognitive processing, within a
social context, with an emphasis on enjoyment holds great
promise.
There were a number of limitations. It should be noted
that this study was limited due to the rigorous inclusion
criteria which were necessary to ensure a homogeneous
group of participants. This meant many participants withJournal of Aging Research 5
related neurological conditions and complex health prob-
lems were excluded. Another limitation was the study sites
which were selected by socioeconomic status (SES) (four
high SESand four middle to lowSES),which allowed diverse
seniorcenterswith 3–7candidatestoparticipate.These small
groups enhanced project diversity enrollment but provided
less than ideal program sizes which may have inﬂuenced
outcomes. Recruitment and retention in lower SES sites was
a problem. Although groups of 10 were recruited in senior
centers, participants did not attend routinely, preferring to
take part in other activities or simply not attending after
group assignment. Several eﬀorts were made to encourage
participation with phone followups, discussions with family
or staﬀ members at the sites, but the attrition rate for the
control condition was much higher than expected.
In clinical practice, outside of a research trial, partici-
pants and groups would be best selected through clinical
judgment, considering complexities like sensory impair-
ment, communication deﬁcits, interest, and mix of par-
ticipants instead of SES and diversity recruitment. In the
randomization procedure, ideally the generation of the
allocation sequence, enrollment into the trial, and allocation
to group should be separate and performed by diﬀerent,
independent staﬀ. The PI and Project Director were directly
involved with this process with the statistician due to an
initial budget cut from the trial funder.
Many more people are being diagnosed earlier in the
course of memory loss because of improving sensitivity and
speciﬁcity of diagnostic techniques and increased awareness
of Alzheimer’s disease and related disorders. Medical, nurs-
ing, allied health professionals, the Alzheimer’s Association,
andotherorganizations areresponding byoﬀeringarangeof
support groupsto ease the social strains ofpeoplewith early-
stage dementia. While these support services are needed,
it appears that the MSA cognitive stimulation intervention
program may be another important option for individuals
with early-stage memory changes, especially if they also have
apathy symptoms. Oﬀeringthis typeof cognitivestimulation
couldinﬂuencethecourseofthediseaseovertimeasourearly
ﬁndings show individuals with early-stage memory loss and
apathyperformwell, improve,andcontinuetoeagerlyattend
twice per week MSA program sessions.
6.Conclusions
Over 70% of people with early-stage Alzheimer’s disease
experience apathy. This symptom is rarely indentiﬁed or
treated, which inhibits the older adult’s ability to remain
active with intellectual, interpersonal, and physical activities.
In light of the high prevalence of apathy in dementia and
its impact on quality of life among older people, the use of
MSA cognitive stimulation groups as a means of reducing
apathyanddepressivesymptoms, aswellasincreasingquality
of life is very appealing. Therapists, nurses, and other aging
services professionals in community settings can incorporate
classroom stylecognitivestimulationsessions for clientswith
dementia and apathy who are underperforming or refusing
to participate in other types of therapeutic programs.
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